Working… Menu
Trial record 44 of 881 for:    "Reticulum Cell Sarcoma"

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00169195
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : September 2, 2015
Hoffmann-La Roche
Eli Lilly and Company
Information provided by (Responsible Party):
Lymphoma Study Association

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2012
Actual Study Completion Date : November 2012
Publications automatically indexed to this study by Identifier (NCT Number):